Vanda Pharmaceuticals Inc. (VNDA) — SC 13G/A Filings
All SC 13G/A filings from Vanda Pharmaceuticals Inc.. Browse 5 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (5)
- SC 13G/A Filing — Feb 13, 2024
- SC 13G/A Filing — Feb 13, 2024
-
Dimensional Fund Advisors Amends Vanda Pharma Stake
— Feb 9, 2024 Risk: low
Dimensional Fund Advisors LP, a Delaware Limited Partnership, filed an amended SC 13G/A on February 9, 2024, indicating its beneficial ownership of Vanda Pharma -
BlackRock Amends Vanda Pharma Stake, Signals Portfolio Shift
— Jan 23, 2024
BlackRock, Inc. filed an amended Schedule 13G/A on January 23, 2024, indicating a change in their ownership stake in Vanda Pharmaceuticals Inc. as of December 3 -
State Street Corp. Updates Passive Stake in Vanda Pharma
— Jan 22, 2024
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 22, 2024, indicating its ownership of Vanda Pharmaceuticals Inc. c
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX